Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × donafenib × Clear all

NCT02489214 2023-05-08

Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer

Phase 1/2 Terminated

Gastrointestinal

Stomach Neoplasms